Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms

Diabetes mellitus has been demonstrated to be closely associated with osteoporosis. Accordingly, hypoglycemic therapy is considered effective in treating metabolic bone disease. Recently, the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors, a new type of antidiabetic drug, on bone metabolism ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yinqiu, Zhao, Chenhe, Liang, Jing, Yu, Mingxiang, Qu, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524773/
https://www.ncbi.nlm.nih.gov/pubmed/28790917
http://dx.doi.org/10.3389/fphar.2017.00487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524773/
https://www.ncbi.nlm.nih.gov/pubmed/28790917
http://dx.doi.org/10.3389/fphar.2017.00487

Ejemplares similares